Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
6
2019
HHS Proposes to Amend AKS Safe Harbors to Exclude PBM Rebates and Incentivize Consumer Drug Discounts Robinson & Cole LLP
Feb
6
2019
OIG Advisory Opinion Allows Smartphone Loan for Needy Patients Taking Digital Drug Mintz
Feb
6
2019
New York City, Ohio, and Maine Crackdown on Food Products with CBD Keller and Heckman LLP
Feb
6
2019
FDA Extends Deadline for eCTD Submissions of Type III DMFs to May 2020 Keller and Heckman LLP
Feb
5
2019
FDA Expands Big Data Use with Sentinel System Faegre Drinker
Feb
5
2019
More States Attempt to Ban Sodas from Kids’ Meals Keller and Heckman LLP
Feb
4
2019
Court Rules En Banc for Injunction Against San Francisco’s Health Warning Requirement for Soft Drink Ads Keller and Heckman LLP
Feb
2
2019
ACGIH® TLV®-CS Committee Seeks Information on Carbon Nanotubes Bergeson & Campbell, P.C.
Feb
1
2019
HHS Proposes New Rules To Eliminate Drug Rebates and Encourage Direct Discounts for Federal Beneficiaries Foley & Lardner LLP
Feb
1
2019
HHS Proposes to Remove Drug Rebate Protections Mintz
Feb
1
2019
Cannabis Quick Hits Keller and Heckman LLP
Feb
1
2019
Sugar-Sweetened Beverages, Conflict Minerals And The First Amendment Allen Matkins Leck Gamble Mallory & Natsis LLP
Jan
31
2019
OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor Robinson & Cole LLP
Jan
31
2019
Raw Turkey Pet Food Linked to Human Illness in Minnesota Keller and Heckman LLP
Jan
30
2019
Recent Developments in the Battle over the Affordable Care Act’s Contraception Mandate Mintz
Jan
30
2019
FDA Issues Draft Guidance Related to Biomarker Qualification Epstein Becker & Green, P.C.
Jan
30
2019
American Lung Association Finds States, Federal Government Failed to Act to Reduce Tobacco Use Keller and Heckman LLP
Jan
29
2019
FDA Issues Final Guidance On Medical Device Safety And Performance-Based Pathway Barnes & Thornburg LLP
Jan
29
2019
What Will “Heightened” Online Age-Verification Look Like? FDA Forthcoming Online Age Verification Requirements for Vapor Products May Mirror California Rules Keller and Heckman LLP
Jan
29
2019
New Kickback Law Targeting Opioid Treatment Facilities Could Affect Traditional Lab Arrangements Dinsmore & Shohl LLP
Jan
29
2019
Plant-Based Milk Labeling Comment Period Ends; Debate Continues Keller and Heckman LLP
Jan
29
2019
ML Strategies Health Care Preview - Week of January 28, 2019 Mintz
Jan
28
2019
Secret Sales Still Qualify as Prior Art McDermott Will & Emery
Jan
28
2019
FDA and USDA Are Back to Work, But Getting Back to “Normal” May Still Take Time Keller and Heckman LLP
Jan
26
2019
Illinois Supreme Court: BIPA Plaintiffs Are Not Required to Show Actual Harm To Have Standing Proskauer Rose LLP
Jan
26
2019
NIOSH Publishes Nanotechnology Research Plan for 2018-2025 Bergeson & Campbell, P.C.
Jan
25
2019
New Guidance Document Reviews Global Packaging Materials Definitions Keller and Heckman LLP
Jan
25
2019
CMS Addresses Drug Manufacturer Coupons in Proposed 2020 Payment Notice Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins